Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Teitell
University of California Los Angeles, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
NanoCav, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
PI is the head of the study and PI received payment for consulting services. PI has equity interest and IP with company.
(PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy
PROJECT NARRATIVE (NOTE: blue text indicates main resubmitted changes) Our proposal addresses NCI Provocative Question 5 (PQ5) that is concerned with the role of mitochondrial heterogeneity in tumorigenesis and cancer progression. Recent studies show that an unexpected source of mitochondrial heterogeneity in tumors that drives tumor progression and therapy resistance arises from the transfer of mitochondria containing mitochondrial DNA (mtDNA) into tumor cells by endocytosis and tunneling nanotubes. We are uniquely qualified and positioned to address the fate of transferred mitochondria and mtDNA in tumor cells from our co-invention of a large cargo transfer device that enables dissection of the role that this transfer plays in tumor heterogeneity, increased tumor aggressiveness and spread, and acquired therapeutic resistance.
Filed on April 12, 2019.
Tell us what you know about Michael Teitell's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Teitell filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav, LLC | $10,000 - $19,999 |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav LLC | $5,000 - $9,999 |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav LLC | Value cannot be readily determined |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav LLC | Value cannot be readily determined |
| Michael Teitell | University of California Los Angeles | Conflict of Interest | NanoCav, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.